Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study.
Jeongseok KimHyuk YoonNayoung KimKang-Moon LeeSung-Ae JungChang Hwan ChoiEun Soo KimYunho JungChang Soo EunTae Oh KimSang-Bum KangYou Sun KimGeom-Seog SeoChang Kyun LeeJong Pil ImSoo Jung ParkDong Il ParkByong Duk YePublished in: Inflammatory bowel diseases (2022)
Among Korean patients with CD or UC for whom anti-tumor necrosis factor therapy failed, VDZ induction therapy was effective and safe. The early clinical response was associated with clinical remission after VDZ induction therapy.